We are live on ! Find out more
IMCR icon

Immunocore
IMCR

47 hedge funds and large institutions have $617M invested in Immunocore in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

10% more capital invested

Capital invested by funds: $561M → $617M (+$56.2M)

4% more funds holding

Funds holding: 45 → 47 (+2)

4.08% more ownership

Funds ownership: 34.69% → 38.78% (+4.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
47
Holders Change
+2
Holders Change %
+4.44%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
15
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$32M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$25.7M
3
APM
Avidity Partners Management
Texas
+$16.7M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$8.04M
5
First Manhattan
First Manhattan
New York
+$6.68M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$14.1M
2
BlackRock
BlackRock
New York
-$8.52M
3
TCM
Tybourne Capital Management
Hong Kong
-$5.4M
4
Citadel Advisors
Citadel Advisors
Florida
-$971K
5
JGC
J. Goldman & Co
New York
-$652K
Name Holding Trade Value Shares
Change 		Change in
Stake
PVI
26
Pura Vida Investments
New York
$1.85M +$1.69M +50,000 New
TD Asset Management
27
TD Asset Management
Ontario, Canada
$1.02M – – –
Legal & General Group
28
Legal & General Group
United Kingdom
$933K +$209K +6,186 +32%
MWNA
29
Marshall Wace North America
New York
$932K – – –
Citadel Advisors
30
Citadel Advisors
Florida
$835K -$971K -28,782 -56%
EMG
31
ETF Managers Group
New Jersey
$603K +$106K +3,130 +24%
UBS Group
32
UBS Group
Switzerland
$519K +$67.1K +1,987 +17%
Victory Capital Management
33
Victory Capital Management
Texas
$353K – – –
BFM
34
Boothbay Fund Management
New York
$253K +$26K +770 +13%
State Street
35
State Street
Massachusetts
$230K +$209K +6,200 New
Geode Capital Management
36
Geode Capital Management
Massachusetts
$222K – – –
VEA
37
Virtus ETF Advisers
New York
$199K -$9.28K -275 -5%
GWM
38
Geneos Wealth Management
Colorado
$163K +$143K +4,250 New
SFM
39
Sphera Funds Management
Israel
$157K +$143K +4,235 New
Zurich Cantonal Bank
40
Zurich Cantonal Bank
Switzerland
$143K – – –
Morgan Stanley
41
Morgan Stanley
New York
$86K +$77.7K +2,301 +11,505%
Bank of America
42
Bank of America
North Carolina
$84K +$71.1K +2,108 +1,454%
CSS
43
Cubist Systematic Strategies
Connecticut
$19K +$16.9K +500 New
SOW
44
State of Wyoming
Wyoming
$5K -$2.33K -69 -33%
Osaic Holdings
45
Osaic Holdings
Arizona
$4K -$203 -6 -5%
HI
46
Harbour Investments
Wisconsin
$1K – – –
DM
47
Deerfield Management
New York
– -$14.1M -360,966 Closed
TCM
48
Tybourne Capital Management
Hong Kong
– -$5.4M -138,192 Closed
JGC
49
J. Goldman & Co
New York
– -$652K -16,685 Closed
Bank of New York Mellon
50
Bank of New York Mellon
New York
– -$504K -12,896 Closed
1
2
3

IMCR Hedge Fund Activity: Q3 2021 in Review

47 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Immunocore (IMCR) for Q3 2021, worth a combined $617M — up 10% from $561M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new IMCR positions and 5 closed out — a net gain of 2 holders — while 15 added to existing stakes and 8 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $32M. The largest seller was Deerfield Management, exiting entirely with an estimated $14.1M sold.

  • 47 institutional investors held Immunocore (IMCR) as of Q3 2021, up from 45 in Q2 2021.
  • Funds reported $617M of Immunocore stock for Q3 2021, up 10% quarter-over-quarter.
  • 7 funds opened new Immunocore positions in Q3 2021 and 5 closed out, a net change of +2 holders.
  • The largest Immunocore buyer in Q3 2021 was Fidelity Investments, an estimated $32M added.
  • The largest Immunocore seller in Q3 2021 was Deerfield Management, an estimated $14.1M sold.

Based on aggregated 13F filings for Q3 2021.